COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 1212: Articles 12111-12120  | Next

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Ma, H., Guo, Y., Tang, H., Tseng, C.-T., Wang, L., Zong, H., Wang, Z., He, Y., Chang, Y., Wang, S., Huang, H., Ke, Y., Yuan, Y., Wu, M., Zhang, Y., Drelich, A., Kempaiah, K., Peng, B.-H., Wang, A., Yang, K., Yin, H., Liu, J., Yue, Y., Xu, W., Zhu, S., Ji, T., Zhang, X., Wang, Z., Li, G., Liu, G., Song, J., Mu, L., Xiang, Z., Song, Z., Chen, H., Bian, Y., Zhang, B., Chen, H., Zhang, J., Liao, Y., Zhang, L., Yang, L., Chen, Y., Gilly, J., Xiao, X., Han, L., Jiang, H., Xie, Y., Zhou, Q., Zhu, J.
10.1101/2021.09.24.461616 — Posted: 2021-09-25
Comparison of adverse events between COVID-19 and Flu vaccines
Pradhan, P. M., Li, C., Shen, Z., Remucal, M. J.
10.1101/2021.09.22.21263711 — Posted: 2021-09-25 Discussion: Offsite
Covid-19 Per Capita Fatality Rate: A Path Analysis Model
Penuliar, M. S., Clark, C., Curti, D., Carrasco, M., Hudson, C., Philips, B.
10.1101/2021.09.22.21263976 — Posted: 2021-09-25
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication by targeting its major protease in a non-competitive way
Chaves, O. A., Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., Pereira-Dutra, F., Mizurini, D. M., Monteiro, R. Q., Vazquez, L., Bozza, P. T., Castro-Faria-Neto, H. C., Souza, T. M. L.
10.1101/2021.09.23.461605 — Posted: 2021-09-24
High-throughput super-resolution analysis of influenza virus pleomorphism reveals insights into viral spatial organization
McMahon, A., Andrews, R., Ghani, S. V., Cordes, T., Kapanidis, A. N., Robb, N. C.
10.1101/2021.09.23.461536 — Posted: 2021-09-24
Tracking the temporal variation of COVID-19 surges through wastewater-based epidemiology during the peak of the pandemic: a six-month long study in Charlotte, North Carolina
Barua, V. B., Juel, M. A. I., Blackwood, A. D., Clerkin, T., Ciesielski, M., Sorinolu, A. J., Holcomb, D. A., Young, I., Kimble, G., Sypolt, S., Engel, L. S., Noble, R. T., Munir, M.
10.1101/2021.09.23.21258047 — Posted: 2021-09-24
Fitting the Reproduction number from UK coronavirus case data, and why it is close to 1
Ackland, G. J., Ackland, J. A., Antonioletti, M., Wallace, D. J.
10.1101/2021.09.23.21256065 — Posted: 2021-09-24
Validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) to screen for SARS-CoV-2 infection in Sint Maarten: a diagnostic accuracy study
King, C., Lista-de Weever, E., Henry, M., Steingrover, R., Fleming, C., Panneflek, R., van Kampen, S.
10.1101/2021.09.23.21260526 — Posted: 2021-09-24
A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2
Brochot, E., Souplet, V., Follet, P., Ponthieu, P., Olivier, C., Even, G., Audebert, C., Malbec, R.
10.1101/2021.09.23.21262329 — Posted: 2021-09-24
Plasma S-Adenosylmethionine is Associated with Lung Injury in COVID-19
Kryukov, E., Ivanov, A., Karpov, V., Alexandrin, V., Dygai, A., Kruglova, M., Kostiuchenko, G., Kazakov, S., Kubatiev, A.
10.1101/2021.09.23.21262822 — Posted: 2021-09-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).